Dr. David J Andorsky
Claim this profileRocky Mountain Cancer Centers USOR
Studies Leukemia
Studies Myeloid Leukemia
9 reported clinical trials
13 drugs studied
Area of expertise
1Leukemia
BCR-ABL1 positive
T315I negative
T315I positive
2Myeloid Leukemia
BCR-ABL1 positive
T315I negative
T315I positive
Affiliated Hospitals
Clinical Trials David J Andorsky is currently running
Asciminib vs Nilotinib
for Chronic Myeloid Leukemia
The study is designed to compare the tolerability of asciminib versus nilotinib for the treatment of newly diagnosed, previously untreated patients with Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP).
Recruiting3 awards Phase 3
Avutometinib + Sotorasib
for Lung Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with sotorasib with or without defactinib in patients with KRAS G12C Non-Small Cell Lung Cancer (NSCLC) in patients who have been exposed to prior G12C inhibitor and those who have not been exposed to prior G12C inhibitor.
Recruiting1 award Phase 1 & 2
More about David J Andorsky
Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments David J Andorsky has experience with
- Asciminib
- Nilotinib
- Tazemetostat
- Rituximab
- ABL001
- Bosutinib
Breakdown of trials David J Andorsky has run
Leukemia
Myeloid Leukemia
Chronic Myeloid Leukemia
Chronic Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David J Andorsky specialize in?
David J Andorsky focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved BCR-ABL1 positive patients, or patients who are T315I negative.
Is David J Andorsky currently recruiting for clinical trials?
Yes, David J Andorsky is currently recruiting for 4 clinical trials in Boulder Colorado. If you're interested in participating, you should apply.
Are there any treatments that David J Andorsky has studied deeply?
Yes, David J Andorsky has studied treatments such as Asciminib, Nilotinib, Tazemetostat.
What is the best way to schedule an appointment with David J Andorsky?
Apply for one of the trials that David J Andorsky is conducting.
What is the office address of David J Andorsky?
The office of David J Andorsky is located at: Rocky Mountain Cancer Centers USOR, Boulder, Colorado 80304 United States. This is the address for their practice at the Rocky Mountain Cancer Centers USOR.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.